The extent to which a person's behaviour (in terms of taking medication, following diets or implementing other lifestyle changes) coincides with medication or health advice
Compliance
The extent to which a person's behaviour- taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider
Persistence
A measure of the duration of treatment
Concordance
The work of the prescriber and the patient in the consultation is a negotiation between equals and that therefore the aim is for a therapeutic alliance between them
Non-compliance or non-adherence: The patient is viewed to be at fault, irrational in decision making about taking their medications, denies the legitimacy of patient choice, does not consider the patient-health professional relationship
To take medications appropriately
Motivated
Competent
Prescribers and Pharmacists should consider patients' beliefs about their disease and therapy, and patients' ability to take their medication
Success of a treatment depends on effectiveness of the medication and adherence to therapy
Correct treatment, appropriate for the patient, prescribed appropriately
Pharmacist's role
Establishing concordance with patients and ensuring a patient-centred approach to care
Information giving (medication and disease state to patient and physician)
Counselling and patient education
Monitoring of effectiveness of therapy
Provision of behavioural strategies to assist with adherence
Medicine taking statistics
1/3 of prescriptions written are never dispensed
20-80% of patients adhere to therapy
50-90% adherence rate to chronic regimens
20-60% of elderly adhere to therapy
Adherence to short term therapy better than long term
Adherence is greatly reduced in the first 10 days
50% discontinued their lipid lowering therapy within 6 months of starting
10% of all hospitalisations and 23% of nursing home admissions are due to non-compliance
Non-adherence rates by condition
Asthma - 20%
Arthritis - 55-71%
Contraception - 8%
Diabetes - 40-50%
Epilepsy - 30-50%
Hypertension - 40%
Patient adherence rates by condition
High Blood Pressure - 72%
Hypothyroidism - 68%
Type 2 Diabetes - 65%
Seizure Disorders - 61%
High Cholesterol - 55%
Extent of non-adherence
Analgesic treatment for cancer pain - 51% took 60% of analgesic dose
Oncology outpatients - 41% of patients were adherent to their prescribed analgesic regimen
Self-reported adherence to analgesia for cancer pain - 51% reported lower levels of adherence; only 8.9% of patients were in the high–analgesic adherence group
70%–90% of cancer patients experience pain (final stages of cancer), but non-adherence rates ranging from 20%–33%
Medication adherence to DMARDs in RA ranged from 30% to 107%
Poor adherence
Poor health outcomes
Increased use of the healthcare system
Increased healthcare costs
Increased costs for the patient and public
Adherence rates
Hospitalisation rates
Improving adherence enhances patient safety and has greater impact on health than improvements in specific medical treatments
Patients need to be supported, not blamed
Classification of non-adherence
Primary
Secondary
Intentional
Non-intentional
Underdoser, overdoser, random
Drug holiday taker, time depend
Patient adherence with therapy leads to
Improve patient's health
Reduce morbidity and mortality
Reduce costs associated with hospital admissions, alternative drug regimens and healthcare professional costs
Poor adherence is a worldwide problem- 50% for chronic therapy
Consequences- poor health outcomes and increased healthcare costs
Improving adherence enhances patient safety
Increasing adherence has greater impact on health than improvements in specific medical treatments
Classification of Non-adherence
Primary
Secondary
Intentional
Non-intentional
Types of Primary Non-adherence
Underdoser
Overdoser
Random
Types of Secondary Non-adherence
Drug holiday taker
Time dependent
Previsit adherent
Symptom dependent
Patient medication adherence - journey
1. Initiation
2. Implementation
3. Discontinuation
Primary non-adherence occurs at the Rx Prescriber Pharmacy Patient Dispensing stage
Secondary non-adherence occurs at the Initiation Implementation Discontinuation stage and can be intentional and unintentional
WHO Dimensions of Factors Influencing
Patient
Healthcare team
Condition
Therapy
Social / Economic
Necessity-ConcernsFramework
Necessity of takingmedication
Benefits of treatment
Concernsaboutmedications (Cost, Side effects)
Examples of Factors
Long duration of treatment
Large number of medications
High cost of medications
Forgetfulness
Loss of faith in the medication
Health beliefs and attitudes
Poor sight or memory
Low income
Low level of education
Major Predictors
Polypharmacy
Cost
Difficulty Taking meds
Memory
Access to Dr Or Pharmacist
Literacy/Health literacy
Language Difficulties
Side effects
Major Predictors (Healthcare Provider)
Clinical Knowledge
Adherence Knowledge
Single Patient Education
Communication Skills
Attitude
Time or Willingness
Adherence Measures
Direct (Blood levels, Direct observation, Biological markers)